Dr Marion Mafham
Clinical Research Fellow, CTSU
- Honorary Consultant Nephrologist, Oxford Kidney Unit
Marion Mafham studied medicine at the University of Edinburgh (1992-1998). In 2003, she joined the Renal Studies Group at CTSU for 3 years as a research fellow, working on the Study of Heart and Renal Protection. During this time she completed an MD thesis examining the relationship between measures of kidney function and cardiovascular risk factors and cardiovascular events. After completing her specialist training in Nephrology, she returned to CTSU in 2013, to work with Professor Jane Armitage in the Heart Studies Group. She is also an Honorary Consultant Nephrologist in the Oxford University Hospitals NHS trust.
PCSK9 inhibition: ready for prime time in CKD?
Mafham M. and Haynes R., (2018), Kidney Int, 93, 1267 - 1269
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes.
Bowman L. et al, (2018), Am Heart J, 198, 135 - 144
Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.
Mafham MM. et al, (2018), Nephrol Dial Transplant, 33, 257 - 264
Telephone support for mail based recruitment and follow-up in a large randomized trial
Chen F. et al, (2017), TRIALS, 18
Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection.
Reith C. et al, (2017), BMC Nephrol, 18